Abstract
A large body of evidence suggests that intrauterine growth restriction (IUGR) impedes normal neurodevelopment and predisposes the offspring to cognitive and behavioral deficits later in life. A significantly higher risk rate for schizophrenia (SZ) has been reported in individuals born after IUGR. Oxidative stress and neuroinflammation are both involved in the pathophysiology of SZ, particularly affecting the structural and functional integrity of parvalbumin interneurons (PVI) and their perineuronal nets (PNN). These anomalies have been tightly linked to impaired cognition, as observed in SZ. However, these pathways remain unexplored in models of IUGR. New research has proposed the activation of the MMP9-RAGE pathway to be a cause of persisting damage to PVIs. We hypothesize that IUGR, caused by a maternal protein deficiency during gestation, will induce oxidative stress and neuroinflammation. The activation of these pathways during neurodevelopment may affect the maturation of PVIs and PNNs, leading to long-term consequences in adolescent rats, in analogy to SZ patients. The level of oxidative stress and microglia activation were significantly increased in adolescent IUGR rats at postnatal day (P)35 as compared to control rats. PVI and PNN were decreased in P35 IUGR rats when compared to the control rats. MMP9 protein level and RAGE shedding were also increased, suggesting the involvement of this mechanism in the interaction between oxidative stress and neuroinflammation. We propose that maternal diet is an important factor for proper neurodevelopment of the inhibitory circuitry, and is likely to play a crucial role in determining normal cognition later in life, thus making it a pertinent model for SZ.
Similar content being viewed by others
Introduction
Schizophrenia (SZ) is a complex neurodevelopmental disease, which etiopathology involves the interaction between genetic and environmental risk factors [1,2,3,4,5]. This interaction during specific, sensitive periods of brain development underlies the vast heterogeneity of symptoms, among which cognitive deficits are the earliest to appear [6,7,8]. Adverse environmental events that have been described to increase the risk for SZ are maternal infections, obstetrical complications, maternal stress, and nutritional deficiencies during the perinatal period [7, 9,10,11,12,13,14]. More specifically, evidence has shown that low caloric intakes during pregnancy increase the lifetime risk for SZ [1], as was observed in individuals conceived during famines that occurred in the Netherlands (1944–1945) and China (1959–1961) [9, 15, 16]. Indeed, recent studies have highlighted the potential role of intrauterine growth restriction (IUGR) in the pathophysiology of psychiatric neurodevelopment diseases, such as SZ [17,18,19]. IUGR [20] is widely considered to be a predisposing factor to several non-transmissible diseases such as cardiovascular and renal disorders [21,22,23]. In addition to significantly impacting birth weight [20, 24], IUGR has also been correlated with impaired cerebral development [20, 25, 26] and adverse cognitive outcomes, such as lower IQ and reduced working memory [24, 27], occurring even many years after the adverse environmental exposure. Interestingly, these features are also found in SZ patients at the early stages of the disease, suggesting a role of IUGR in the pathophysiology of SZ. To understand the mechanisms by which IUGR may lead to brain impairments related to SZ, IUGR was modeled in animals as gestational caloric restriction or isocaloric protein restriction [28,29,30,31]. More recently, IUGR induced by moderate under-nutrition has been demonstrated to cause mild cerebral impairments such as delayed cortical synaptogenesis and myelination, increased oxidative damage, and inhibitory circuitry impairments [30]. Despite this recent study, little is known about the mechanism induced by IUGR that could lead to changes in inhibitory brain circuitry during development.
Interestingly, oxidative stress, neuroinflammation [9, 32,33,34,35,36,37,38] as well as impairment of the structural and functional integrity of parvalbumin-expressing fast-spiking interneurons (PVI) [39] and their surrounding perineuronal net (PNN) [40,41,42,43] were established as hallmarks of SZ pathophysiology [32, 44,45,46]. PVI are particularly sensitive to oxidative stress and neuroinflammation during the early postnatal period [47,48,49,50], supporting a major role of environmental stressors occurring during a well-defined period of brain development [10, 51, 52]. The interaction between oxidative stress and neuroinflammation during the early postnatal stage was shown to impair PV/PNN maturation in an animal model of redox dysregulation with a SZ-like phenotype [47, 53]. This interaction was mediated by the activation of the matrix metalloproteinase 9 (MMP9) which induces the shedding of the receptor for advanced glycation end-product (RAGE), leading to a feedforward loop of oxidative stress and neuroinflammation [53], deleterious for PVI maturation. Therefore, the MMP9/RAGE mechanism may be a good candidate for the induction of PVI impairments and further brain development deficits, underlying the adverse cognitive outcomes induced by IUGR.
The focus of this study is to assess whether a maternal low protein diet exposes the offspring to a higher risk of oxidative stress and microglia activation, leading to a deleterious impact on the neurodevelopment of PVIs and their PNNs.
Material and methods
Animal model
IUGR in pregnant Sprague Dawley rats (240–294 g, Charles River, L’Arbresle, France) were prepared as previously described [29, 31] (Suppl Fig. 1). These experiments were approved by the ethics committee for animal research at the University of Lausanne, Switzerland. Rats had free access to water and were kept at standard laboratory conditions with controlled temperature and humidity, under a 12-h light/dark cycle. Briefly, pregnant dams belonging to the control group are exposed to a diet composed of 23% casein (representing a normal isocaloric diet; SAFE U8959, version 1, Augy, France), while dams from the IUGR group are fed with an isocaloric diet composed of 9% casein (low protein; SAFE U8959, version 40). Both diets begin at gestational day 1 (G1), defined as the day on which sperm was detected in the vaginal smear, and maintained ad libitum until birth. A normal diet was administrated at birth and until the date of sacrifice, on postnatal day (P35). The control group consisted of 5 rats and the IUGR group of 7. Pregnant dams were assigned randomly to the control or the IUGR group. Only males were used for this study, which was approved by the Swiss cantonal veterinary office.
Rats were anesthetized at P35 for intracardial perfusion with filtered 4% paraformaldehyde in PBS, pH 7.4 solution, enabling brain fixation. Brains were dissected and post-fixed for storage in 30% sucrose. 50 µm coronal sections of the rat brains were prepared with a microtome (Microm HM440E) for immunohistochemistry procedure. Coronal sections were stored in ethylene-glycol for preservation at −20 °C.
Immunofluorescence
For each rat (n = 5–7), brain sections (3–4 sections per rat) containing our region of interest (the anterior cingulate cortex) were used for IH quantification of proteins. The following antibodies were incubated at 4 °C for 48 h: anti-Iba1 (1:1000; Abcam, ab5076), anti-CD68 (1:1500; Abcam, ab53444), anti-8-oxoDG (8-Oxo-2’-deoxyguanosine) (1:350; Trevigen, 4354-MC-050), anti-PV (1:50,000; Swant, PV 25), anti-SST (1:100; Millipore; MAB354), anti-WFA (Wisteria Floribunda Lectin) for PNN staining (1:50,000; Sigma, L1516), anti-extracellular RAGE (1:300; MAB1179, R&D systems), anti-intracellular RAGE (1:500; ab3611, Abcam), and anti-MMP9 (1:500; Santa Cruz, sc-10737). Sections were then incubated with fluorescent secondary antibody: goat anti-mouse (1:300; A488; Life Technologies, USA), goat anti-rabbit IgG (1:300; CY3; Chemicon International, USA), streptavidin 405 conjugate (1:300; A405; Millipore Corporation, USA), and chicken anti-goat Alexa 594 (1:300, A494: Abcam, UK). For the staining of membrane-bound RAGE and intranuclear RAGE, IH was performed as previously described [53]. Briefly, to identify RAGE shedding, an antibody targeting the extracellular domain of RAGE was used together with another antibody targeting the intracellular domain of RAGE, both revealed with two different secondary antibodies.
Confocal imaging and image analysis
Sections were visualized and processed with a Zeiss confocal microscope (LSM 710 Quasar) controlled by the Zen software (Carl Zeiss AG, Switzerland). Z stacks of 12 images (1.87 µm interval) were scanned (1024 × 1024 pixels, ×20 or ×40 objectives) for analysis with IMARIS 6.4.0 (Bitplane AG, Switzerland). The region of interest (ROI) was marked throughout the Z-stacks ACC images in which the number of PV-immunoreactive (IR) cells, PNN (WFA-labeled PNNs), and SST-expressing neurons were quantified. 8-oxo-dG and Iba-1 labeling intensities were obtained using the Coloc module to calculate 8-oxo-dG and Iba-1 fluorescent intensity (in arbitrary unit: a.u). For RAGE and MMP9 staining, ×40 objective was used, covering the ACC area with 4 images. To obtain the number of PVIs and PVIs surrounded by PNNs (WFA + PVI) the spots module which assigns spot markings to the profile-labeled voxels of a given size (~9 and ~5 µm, respectively) was used. Spots generated for PVI profiles (>9 µm) that touched/overlapped with spots generated for PNN ( > 5 µm) were considered as PVIs surrounded by PNNs (WFA-positive PV). To separately obtain the Iba-1 cell count, spots generated for Iba-1 profiles in the range of 3–5 µm were considered as Iba-1 positive cells.
Statistical analysis
The analyses were done blindly, as different persons were in charge of the animal processing and the immunofluorescence analyses (immunofluorescence processing, confocal scanning and Imaris analyses), and number ID were given to the animals.
The sample size was chosen to detect approximately 25% change in the number of PV-IR cells and approximately 75% change in 8-oxo-dG intensity with a power of 80% at a significant α-value set to p = 0.05. To ensure that the sample size used had adequate power, data was checked using the tool power details in JMP v12.2. The threshold for conservative power was always taken above 0.7. Type 1 error was set at 0.05 (alpha) and the difference to detect between means was taken at the level of 0.7–0.8. Raw data and residuals of the model were checked for normal distribution (with JMP goodness-of-fit and R software) using Shapiro-Wilk Test (with acceptance value probability of p > 0.05) and variance homogeneity was evaluated using Bartlett test Test (with acceptance value probability of p > 0.05). For some of the variables (PV intensity, PNN count, 8-oxo-DG intensity, Iba1 intensity, RAGE ratio), the homogeneity criteria was not met, so the data were converted using logarithmic transformation, which homogenized their variance. Upon detection of a significant main effect in multivariate ANOVA, the mean number of PVI, PNN cells, PVI with PNN (PNN + PVI), MMP9, RAGE, and the overall 8-oxo-dG, Iba-1 intensity/count and CD68 were compared between IUGR and control groups using Dunnett’s method.
Results
Intrauterine protein deficiency does not lead to persistent low body weight
Rats were weighed before being anesthetized at P35 (adolescence). Bodyweight at P35 showed no significant difference between IUGR (132 g ± 9.6) and control (145 g ± 15.3) groups (Table 1). This shows that low-protein induced IUGR during gestation does not define a persistent low postnatal body weight at P35, suggesting that the phenotype described in our study is not related to growth retardation per se.
Intrauterine protein deficiency leads to increased oxidative stress and microglial activation in the ACC
We first investigated whether an intra-uterine low protein diet was sufficient to induce oxidative stress in the anterior cingulate cortex (ACC) of P35 offspring. 8-oxo-dG, which marks DNA oxidation, was used to detect the extent of oxidative stress damage [54]. The ACC of P35 IUGR rats showed significantly higher 8-oxo-dG intensity as compared to control rats (p < 0.0001; Fig. 1), suggesting increased oxidative stress induced by the intrauterine protein deficiency in IUGR rats.
As oxidative stress is tightly linked to neuroinflammation [35], we further explored microglia activation, by analyzing Iba1 intensity and number of cells. Iba-1 immunolabeling revealed an increase of Iba-1-positive cells in the ACC of IUGR rats compared with control rats (p = 0.01) as shown in Fig. 1. Likewise, Iba-1 expression in ACC of IUGR rats, as shown by Iba-1 intensity (a.u), exhibited a significant increase compared to control rats (p = 0.01). Increased microglia activation was further corroborated by an increase in CD68 labeling (p = 0.03) (Fig. 1). These findings indicate that intrauterine protein deficiency-induced IUGR increases the number of activated microglia as well as the protein expression of Iba-1 and CD68 in the ACC of P35 rats.
Altogether, a maternal low protein diet leads to increased oxidative stress and an upregulation of the total number of microglial cells, increasing neuroinflammation, in the ACC of individuals born after IUGR.
Intrauterine protein deficiency impairs PVIs and PNNs maturation in the ACC
To investigate whether the observed oxidative damage and microglia activation in the ACC of intrauterine protein deficiency-induced IUGR rats affects the inhibitory circuitry, we analyzed PV and PNN expressing neurons. We found that the immunolabeling intensity of PV but also the number of PV-IR cells were lower (PV count: p < 0.0001 and PV intensity: p < 0.05) in the ACC of IUGR rats compared with those of control rats (Fig. 2). This suggests a predominant decrease in the number of PVI, more than the amount of PV protein that they express. Interestingly, somatostatin (SST)-IR cells were also decreased in the IUGR rats, suggesting other impairments in the inhibitory circuitry induced by the intrauterine protein deficiency (Fig. 2).
Furthermore, intrauterine protein deficiency significantly impaired the extracellular matrix component as revealed by WFA (a lectin that recognizes PNN around PVI) intensity (p < 0.01) and WFA-IR (PNN) cell count (p < 0.001) as compared to control rats. Double-immunofluorescent labeling for WFA-positive PVI showed a significantly reduced number of WFA-IR PV-IR cells (p < 0.0001) in the ACC of P35 IUGR rats when compared to control rats (Fig. 2).
MMP9/RAGE mechanism is induced in the ACC by intrauterine protein deficiency
Environmental insults inducing oxidative stress and neuroinflammation may affect the maturation of PV/PNN. As previously observed, oxidative stress activates MMP9 and RAGE shedding, which together leads to a feedforward loop of oxidative stress and neuroinflammation, impairing PVI maturation [53]. We investigated whether this mechanism may be induced by IUGR and affect PVI/PNN. MMP9-IR cell number was increased in the IUGR rats (p < 0.05) as compared to controls (Fig. 3). RAGE shedding, revealed by the ratio of intra-nuclear RAGE staining over the membrane-bound RAGE [53], was also increased in the IUGR rats (p < 0.001), indicating increased RAGE shedding induced by MMP9.
Correlation of oxidative stress/microglia activation markers with PVI deficits
In order to estimate a link between the oxidative stress and/or microglia activation with the PVI maturation impairments, Iba1, CD68 and 8-oxo-DG were correlated with PV-IR cells count. Interestingly, these different markers were all negatively correlated with PV, as increased oxidative stress and microglia activation were associated with decreased PV (Fig. 4). Moreover, MMP9 was negatively correlated with PNN, in line with a potential role of this MMP in PNN degradation (Fig. 4). Intriguingly, PV decrease was also associated with increased RAGE shedding, suggesting a role of this process in PVI impairments (Fig. 4).
Discussion
Overall, our results show that IUGR induced by a low protein diet leads to increased oxidative stress and microglial activation, MMP9/RAGE mechanism activation, leading to the impairment of PVI and PNN maturation at P35. To our knowledge, no studies to date have pinpointed the pathophysiological mechanism linking prenatal malnutrition to subsequent PVI and PNN impairment. Moreover, our study brings a novel insight into the effect of IUGR on brain development through the role of oxidative stress and microglia activation.
Previous studies have already underlined the impact of maternal nutrition on the mental and physical health of the offspring [20, 24, 55, 56]. Offspring exposed to IUGR show altered neurodevelopment, specifically a delay in synaptogenesis [56]. Lack of nutrients during the critical phase of cerebral development provides a hypothesis for the delay in synaptogenesis. Amino acids, the constituents of protein, are the building blocks of neurons, glial cells, and several neurotransmitters, which are essential for physiological neurodevelopment [20]. Furthermore, an intrauterine low protein diet has been shown to have negative consequences on a multitude of physiological neurological functions, such as an altered morphology of the prefrontal cortex, diminished working memory, and reversal learning [1, 18, 19, 26, 27]. However, the specific neural network and regions affected remain unidentified, as for the underlying mechanisms.
Protein deficiency effect on body weight
We established that there was no significant difference in the protein deficiency-induced IUGR rat’s body weight at P35 compared with that of control rats (Table 1). Whilst not having initial body weights at birth for comparison, previous studies on animal models of gestational low protein diet have shown it to result in low body weight at birth [20, 31, 57]. Based on these previous findings in rat models, we can assume that in our study a significant difference in body weight at birth was later compensated in IUGR rats due to their ad libitum access to an isocaloric diet during the postnatal period. The differences we observed in the ACC of the IUGR P35 rats (Table 1) are therefore not likely to be associated with low body weight at birth, but rather with low protein-associated deficiencies, which occurred during the developmental/gestational period. This suggests that body weight recovery by itself is not sufficient to exclude long-lasting effects caused by an important adverse environmental exposure during gestation (IUGR).
Increased oxidative stress and microglia activation in IUGR
The research presented here attempts to propose new mechanisms to explain the long-lasting adverse effects due to IUGR. Indeed, we propose that part of the deleterious effects of IUGR are mediated by oxidative stress and microglia activation occurring during fetal brain development. Previous animal models of maternal nutrient restriction have demonstrated increased 8-oxo-dG but also 4-HNE, a marker of lipid peroxidation, indicating increased oxidative damage in offspring born after IUGR [30, 56]. In a model of protein deficiency, increased superoxide production via the NADPH oxidase was observed [20, 31], linking the protein availability to ROS generation. Furthermore, low-protein diet-induced IUGR also leads to neuroinflammatory-associated brain injury [26, 58], presumably via uncontrolled microglia increase [20, 57, 59]. Other animal models of IUGR through uterine artery ligation [24, 60] or placenta embolization [24] and chronic hypoxia [24] also showed increased neuroinflammation, as increased microglia and astrocyte activation.
The results gathered through experimental animal models are supported by observations made in pregnant women. In a translational application of this thought, pregnant women with growth-restricted fetuses revealed a measurable increase in plasmatic oxidants [61], a decrease in antioxidant capacities [20, 62], as well as the presence of a pro-inflammatory environment [17], with increased inflammatory cytokines in individuals born after IUGR [63], changes which are similarly observed in IUGR neonates [20, 26, 58]. Findings of increased biomarkers of oxidative stress in cord blood and placental tissue of infants born after IUGR [56] as well as the induction of a pro-inflammatory environment [17, 64, 65] suggest the long-term effect of the impaired environment.
As for animal models, the cause for growth-restricted foetuses may come from malnutrition of the mother during pregnancy, leading to placenta insufficiency. In humans, placental insufficiency is one of the primary causes of IUGR and has multiple origins, including inappropriate substrate availability due to maternal under- or over-nutrition [26]. A maternal low protein diet induces placental insufficiency and secondary IUGR [19]. One hypothesis linking growth restriction to cognitive deficiency is hypoxia caused by placental insufficiency that affects the neurodevelopment despite brain sparing, a compensation mechanism seen in IUGR in which the blood flow to the brain is increased in an attempt to preserve neurodevelopment [27]. Indeed, although few studies link IUGR to oxidative stress and neuroinflammation in the fetus’ later life, there have been studies showing that IUGR causes placental insufficiency which in turn induces chronic fetal hypoxia [24]. Chronic fetal hypoxia has been linked to cytokine imbalances and redox dysregulation [63].
Fetal growth restriction (FGR) animal models have contributed to establishing the effect of hypoxia, subsequent oxidative stress, and inflammation, on neurodevelopment [24]. Alterations following chronic fetal hypoxia are predominant in region-specific zones leading to deficits in neuronal organization and axonal injury [24]. Moreover, various other diseases such as severe preeclampsia are intricately linked to placental insufficiency [24]. Faulty placentation during early gestation may result in preeclampsia. The fetus’ response to oxygen and nutrient restriction has shown to result in a maternal immune response associated with a systemic low-grade pro-inflammatory state [18]. This, in turn, triggers oxidative stress and inflammation in the fetus (e.g., maternal produced IL-6, a pro-inflammatory cytokine that can traverse the placenta into the fetal circulation), which is associated with impaired neurodevelopment and even specific diseases such as autism spectrum disorder and other developmental delays [18].
PVI/PNN impairment and IUGR
IUGR seems to be associated with numerous cerebral abnormalities and in particular, brain connectivity impairment [24]. Although such alterations of neurodevelopment are now widely accepted, mechanisms that might explain the associations are still lacking, as data from IUGR in humans remains scarce.
Neuroinflammatory processes, such as cytokines and microglial activation, but also the redox balance, such as antioxidants and oxidative stress, are highly involved in brain development and maturation during gestation [66, 67]. Given the important role of microglia and oxidative stress during development [68, 69], their impairments may lead to long-lasting anomalies in brain structure maturation. Moreover, should these abnormalities caused by IUGR be maintained into the postnatal period and adolescence, they could be a reason for deleterious neurodevelopment and persistent damage to PVIs and PNNs. Indeed, previous studies have shown a lack of antioxidant capacities (such as glutathione) [35, 53, 54, 70] and the presence of pro-inflammatory cytokines [13], such as IL-6 [9, 18, 71] to be deleterious to neurodevelopment (Suppl Table 1). Based on our present observations and previous studies from our lab [47, 53], we further conclude that redox dysregulation and microglia activation induced by FGR affects the normal maturation of PVIs as well as the proper development of their protective PNNs (Figs. 2 and 3). PVI are involved in higher-order sensory and cognitive information processing and their proper maturation, occurring during the early postnatal period, was shown to be detrimental to cognition [72,73,74,75,76]. Indeed, PVI play a major role in the synchronization of pyramidal neurons, inducing a rhythmical firing at gamma frequencies [77], which were shown to be linked to these higher-order processes in the brain [78, 79]. Increased oscillations at gamma frequency were associated with cognitive performance in control subjects [80] but not in SZ patients [81], suggesting a major role of this neural activity in cognition, with impairments in SZ. Although data links IUGR to a higher risk of neurocognitive disabilities, inattention or behavioral disorders, and lower educational levels [20, 24, 27], the ultimate impact of IUGR requires further rigorous investigation. Whilst the lack of evidence linking low FGR with cognition and neurobehavioral tests is a limitation in this study, the correlation between oxidative stress and microglia activation during development and their impact on PVI circuitry, physiology, and function has been well documented [24, 47, 54, 82, 83]. Interestingly, the interaction between oxidative stress and neuroinflammation was previously found to be mediated by MMP9/RAGE mechanism in an animal model with relevance for SZ [53]. Here, the same mechanism was found to be activated, which may lead to the maintenance of the IUGR mediated oxidative stress and microglia activation until the postnatal period and affect PVI maturation [53]. Of note, MMP9 was found to be increased in growth-restricted preterm newborns during postnatal periods [64], in line with our findings. Further investigation will be needed to understand the role of the MMP9/RAGE mechanism in IUGR-induced oxidative stress and microglia activation.
Studies have shown neurocognitive disabilities as well as behavioral disorders during childhood and adolescence in individuals born after IUGR [20, 24, 57]. These behavioral alterations may resemble, without being equivalent to, SZ symptoms, and therefore strengthen the link between IUGR and neurodevelopmental psychiatric disorders. A maternal low protein diet seemingly impacts proper neurodevelopment through an increase in oxidative stress and neuroinflammation and thus hinders what is considered to be normal behavior [43, 47, 56, 84], which may be relevant for SZ. Many adverse events during gestation, such as infection or traumatic events [32, 85, 86], were shown to be risk factors for SZ, and malnutrition, due to famine episodes [9], were associated with a higher risk of developing SZ in the offspring [9, 15, 16]. Therefore, the hypothesis of IUGR inducing increased oxidative stress and neuroinflammation which affect the proper maturation of PVI/PNN may be relevant for SZ.
While redox dysregulation, microglia activation, PVI and PNN impairments have previously each been individually linked to other developmental models, to our knowledge, there are no studies that have highlighted all of these abnormalities in any IUGR model. Moreover, a potential role of the MMP9/RAGE mechanism has never been studied in this model. By evaluating all of the elements mentioned above, our data provides further understanding into how the convergence of environmental risk factors during a specific time of development could potentially contribute to PVI and PNN dysfunction and altered cognition via redox dysregulation and microglia activation.
A limitation of this study includes the lack of the pup’s birth weight, which would have allowed us to be certain of an initial discrepancy between the two groups at birth. An additional lack of follow-up after P35 prevents us from establishing a possible persistence of the neurodevelopmental abnormalities in the ACC of IUGR rats. Indeed, it may be of interest to investigate the long-term impact of an in utero low protein diet on PVI maturation in adulthood, and not only at P35. Behavioral studies of adults could also add insight into the long-term functional impact of IUGR. Studies have demonstrated that PVI and their PNN evolve throughout an individuals’ lifespan, rendering the results of early insults more severe [47, 54]. Finally, a bigger sample size would be needed to reduce interindividual variability and allow a better comparison of the two groups.
In conclusion, this study emphasizes the deleterious impact of maternal protein deficiency during gestation on PVI and PNN circuitry, even if this deficiency is transient and followed by an unlimited normal diet after birth. A temporary deleterious environment during the prenatal period interferes with neurodevelopment even after the individual is no longer exposed to the harmful context. Further research into the impact of a protein-deficient maternal diet during the prenatal period on neuronal synchronization and ulterior behavior and cognition requires attention, and will most certainly strengthen the pathophysiological hypothesis. Studying other mechanisms in IUGR models will allow a better understanding of their intricate links to oxidative stress and neuroinflammation and will offer new therapeutic possibilities targeting different symptoms observed in SZ. This would also pave the way to a window of opportunity for intervention in patients conceived under IUGR, as more than 22 million new-borns are affected by low birth weight every year [26]. Through a better understanding of the impact of a low protein IUGR on neurodevelopment and the mechanism leading to the deficits observed, this study hopes to add insight into the possible phenotype of SZ in patients born to pregnant women with a protein insufficiency dietary lifestyle.
References
Réthelyi JM, Benkovits J, Bitter I. Genes and environments in schizophrenia: the different pieces of a manifold puzzle. Neurosci Biobehav Rev. 2013;37:2424–37.
Laurens KR, Luo L, Matheson SL, Carr VJ, Raudino A, Harris F, et al. Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. BMC Psychiatry. 2015;15:205.
Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HWM, Rutten BPF. An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry. 2012;17:1194–205.
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
The International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–52.
Fornito A, Yucel M, Dean B, Wood SJ, Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull. 2009;35:973–93.
Fusar-Poli P, Tantardini M, De Simone S, Ramella-Cravaro V, Oliver D, Kingdon J, et al. Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. Eur Psychiatry. 2017;40:65–75.
Shakeel MK, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, et al. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: an outcome based analysis. Schizophr Res. 2019;204:334–6.
Brown AS. The environment and susceptibility to schizophrenia. Prog Neurobiol. 2011;93:23–58.
O’Donnell KJ, Meaney MJ. Fetal origins of mental health: the developmental origins of health and disease hypothesis. Am J Psychiatry. 2017;174:319–28.
Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. Signs of asphyxia at birth and risk of schizophrenia: population-based case–control study. Br J Psychiatry. 2001;179:403–8.
Suvisaari JM, Taxell-Lassas V, Pankakoski M, Haukka JK, Lönnqvist JK, Häkkinen LT. Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull. 2013;39:1056–66.
Brown AS, Meyer U. Maternal immune activation and neuropsychiatric illness: a translational research perspective. Am J Psychiatry. 2018;175:1073–83.
Mongan D, Ramesar M, Föcking M, Cannon M, Cotter D. Role of inflammation in the pathogenesis of schizophrenia: a review of the evidence, proposed mechanisms and implications for treatment. Early Interv Psychiatry. 2020;14:385–97.
St Clair D, Xu M, Wang P, Yu Y, Fang Y, Zhang F, et al. Rates of adult schizophrenia following prenatal exposure to the chinese famine of 1959-1961. JAMA. 2005;294:557–62.
Xu M-Q, Sun W-S, Liu B-X, Feng G-Y, Yu L, Yang L, et al. Prenatal malnutrition and adult schizophrenia: further evidence from the 1959-1961 Chinese famine. Schizophr Bull. 2009;35:568–76.
Faa G, Manchia M, Pintus R, Gerosa C, Marcialis MA, Fanos V. Fetal programming of neuropsychiatric disorders: fetal Programming. Birth Defect Res C. 2016;108:207–23.
Walker CK, Krakowiak P, Baker A, Hansen RL, Ozonoff S, Hertz-Picciotto I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr. 2015;169:154.
Herring CM, Bazer FW, Johnson GA, Wu G. Impacts of maternal dietary protein intake on fetal survival, growth, and development. Exp Biol Med (Maywood). 2018;243:525–33.
Armengaud JB, Yzydorczyk C, Siddeek B, Peyter AC, Simeoni U. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reprod Toxicol. 2021;99:168–76.
Juvet C, Simeoni U, Yzydorczyk C, Siddeek B, Armengaud J-B, Nardou K, et al. Effect of early postnatal nutrition on chronic kidney disease and arterial hypertension in adulthood: a narrative review. J Dev Orig Health Dis. 2018;9:598–614.
Peyter A-C, Armengaud J-B, Guillot E, Yzydorczyk C. Endothelial progenitor cells dysfunctions and cardiometabolic disorders: from mechanisms to therapeutic approaches. Int J Mol Sci. 2021;22:6667.
Sutherland MR, Bertagnolli M, Lukaszewski M-A, Huyard F, Yzydorczyk C, Luu TM, et al. Preterm birth and hypertension risk: the oxidative stress paradigm. Hypertension. 2014;63:12–18.
Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome: fetal growth restriction: brain structure and function. J Physiol. 2016;594:807–23.
Baud O, Berkane N. Hormonal changes associated with intra-uterine growth restriction: impact on the developing brain and future neurodevelopment. Front Endocrinol. 2019;10:9.
Fleiss B, Wong F, Brownfoot F, Shearer IK, Baud O, Walker DW, et al. Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury. Front Endocrinol. 2019;10:188.
Guellec I, Lapillonne A, Renolleau S, Charlaluk M-L, Roze J-C, Marret S, et al. Neurologic outcomes at school age in very preterm infants born with severe or mild growth restriction. Pediatrics. 2011;127:e883–e891.
Grandvuillemin I, Buffat C, Boubred F, Lamy E, Fromonot J, Charpiot P, et al. Arginase upregulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction. Am J Physiol-Regul Integr Comp Physiol. 2018;315:R509–R520.
Armengaud J-B, Dennebouy Z, Labes D, Fumey C, Wilson A, Candotti F, et al. Intra-uterine growth restriction induced by maternal low-protein diet causes long-term alterations of thymic structure and function in adult male rat offspring. Br J Nutr. 2020;123:892–900.
Van de Looij Y, Larpin C, Cabungcal J-H, Sanches EF, Toulotte A, Do KQ, et al. Nutritional intervention for developmental brain damage: effects of lactoferrin supplementation in hypocaloric induced intrauterine growth restriction rat pups. Front Endocrinol. 2019;10:14.
Simoncini S, Coppola H, Rocca A, Bachmann I, Guillot E, Zippo L, et al. Endothelial colony-forming cells dysfunctions are associated with arterial hypertension in a rat model of intrauterine growth restriction. Int J Mol Sci. 2021;22:10159.
Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009;19:220–30.
Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2013;18:206–14.
Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 2013;74:400–9.
Steullet P, Cabungcal JH, Monin A, Dwir D, O’Donnell P, Cuenod M, et al. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a “central hub” in schizophrenia pathophysiology? Schizophrenia Res. 2016;176:41–51.
Meyer U. Developmental neuroinflammation and schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;42:20–34.
Inta D, Lang UE, Borgwardt S, Meyer-Lindenberg A, Gass P. Microglia activation and schizophrenia: lessons from the effects of minocycline on postnatal neurogenesis, neuronal survival and synaptic pruning. SCHBUL. 2016;43:493–6.
Cuenod M, Steullet P, Cabungcal J-H, Dwir D, Khadimallah I, Klauser P, et al. Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia. Mol Psychiatry. 2021;24:1886–97.
Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N, et al. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol. 2011;122:615–26.
Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012;35:57–67.
Pantazopoulos H, Woo T-UW, Lim MP, Lange N, Berretta S. Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch Gen Psychiatry. 2010;67:155.
Mauney SA, Athanas KM, Pantazopoulos H, Shaskan N, Passeri E, Berretta S, et al. Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol Psychiatry. 2013;74:427–35.
Steullet P, Cabungcal J-H, Coyle J, Didriksen M, Gill K, Grace AA, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry. 2017;22:936–43.
Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010;11:100–13.
Grent-’t-Jong T, Gross J, Goense J, Wibral M, Gajwani R, Gumley AI, et al. Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages. eLife. 2018;7:e37799.
Sorg BA, Berretta S, Blacktop JM, Fawcett JW, Kitagawa H, Kwok JCF, et al. Casting a wide net: role of perineuronal nets in neural plasticity. J Neurosci. 2016;36:11459–68.
Cabungcal J-H, Steullet P, Kraftsik R, Cuenod M, Do KQ. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol Psychiatry. 2013;73:574–82.
Komitova M, Xenos D, Salmaso N, May Tran K, Brand T, Schwartz ML, et al. Hypoxia-induced developmental delays of inhibitory interneurons are reversed by environmental enrichment in the postnatal mouse forebrain. J Neurosci. 2013;33:13375–87.
Sullivan EM, O’Donnell P. Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophr Bull. 2012;38:373–6.
Morishita H, Cabungcal J-H, Chen Y, Do KQ, Hensch TK. Prolonged period of cortical plasticity upon redox dysregulation in fast-spiking interneurons. Biol Psychiatry. 2015;78:396–402.
Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 2005;6:877–88.
Gomes FV, Zhu X, Grace AA. The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability. Mol Psychiatry. 2020;25:3278–91.
Dwir D, Giangreco B, Xin L, Tenenbaum L, Cabungcal J-H, Steullet P, et al. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Mol Psychiatry. 2020;25:2889–904.
Cabungcal J-H, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK, et al. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci USA. 2013;110:9130–5.
Pylipow M, Spector LG, Puumala SE, Boys C, Cohen J, Georgieff MK. Early postnatal weight gain, intellectual performance, and body mass index at 7 years of age in term infants with intrauterine growth restriction. J Pediatr. 2009;154:201–6.
Maki Y, Nygard K, Hammond RR, Regnault TRH, Richardson BS. Maternal undernourishment in guinea pigs leads to fetal growth restriction with increased hypoxic cells and oxidative stress in the brain. Dev Neurosci. 2019;41:290–9.
Rideau Batista Novais A, Pham H, Van de Looij Y, Bernal M, Mairesse J, Zana-Taieb E, et al. Transcriptomic regulations in oligodendroglial and microglial cells related to brain damage following fetal growth restriction: FGR and the Developing Brain. Glia. 2016;64:2306–20.
Honório de Melo Martimiano P, de Sa Braga Oliveira A, Ferchaud-Roucher V, Croyal M, Aguesse A, Grit I, et al. Maternal protein restriction during gestation and lactation in the rat results in increased brain levels of kynurenine and kynurenic acid in their adult offspring. J Neurochem. 2017;140:68–81.
Vomhof-DeKrey E, Darland D, Ghribi O, Bundy A, Roemmich J, Claycombe K. Maternal low protein diet leads to placental angiogenic compensation via dysregulated M1/M2 macrophages and TNFα expression in Sprague-Dawley rats. J Reprod Immunol. 2016;118:9–17.
Yzydorczyk C, Armengaud JB, Peyter AC, Chehade H, Cachat F, Juvet C, et al. Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches. J Dev Orig Health Dis. 2017;8:448–64.
Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch. 2004;444:49–55.
Gadhok A, Sharma T, Sinha M, Khunteta R, Vardey S, Sahni P, et al. Natural antioxidant vitamins status in pregnancies complicated with intrauterine growth restriction. Clin Lab 2017. https://doi.org/10.7754/Clin.Lab.2017.161120.
Shen Q, Li ZQ, Sun Y, Wang T, Wan CL, Li XW, et al. The role of pro-inflammatory factors in mediating the effects on the fetus of prenatal undernutrition: Implications for schizophrenia. Schizophr Res. 2008;99:48–55.
McElrath T, Allred E, Van Marter L, Fichorova R, Leviton A. ELGAN Study Investigators. Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr. 2013;102:e439–e442.
Lai JCY, Rocha-Ferreira E, Ek CJ, Wang X, Hagberg H, Mallard C. Immune responses in perinatal brain injury. Brain Behav Immun. 2017;63:210–23.
Bilbo SD, Schwarz JM. The immune system and developmental programming of brain and behavior. Front Neuroendocrinol. 2012;33:267–86.
Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15:300–12.
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017;2017:1–13.
Hardingham GE, Do KQ. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci. 2016;17:125–34.
Koga M, Serritella AV, Sawa A, Sedlak TW. Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res. 2016;176:52–71.
Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM, et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res. 2010;121:46–54.
Bertrand O, Tallon-Baudry C. Oscillatory gamma activity in humans: a possible role for object representation. Int J Psychophysiol. 2000;38:211–23.
Howard MW. Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 2003;13:1369–74.
Ferguson BR, Gao W-J. PV interneurons: critical regulators of e/i balance for prefrontal cortex-dependent behavior and psychiatric disorders. Front Neural Circuits. 2018;12:37.
Kim H, Ährlund-Richter S, Wang X, Deisseroth K, Carlén M. Prefrontal parvalbumin neurons in control of attention. Cell. 2016;164:208–18.
Hu H, Gan J, Jonas P. Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function. Science. 2014;345:1255263.
Penttonen M, Kamondi A, Acsády L, Buzsáki G. Gamma frequency oscillation in the hippocampus of the rat: intracellular analysis in vivo. Eur J Neurosci. 1998;10:718–28.
Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459:698–702.
Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009;459:663–7.
Parciauskaite V, Voicikas A, Jurkuvenas V, Tarailis P, Kraulaidis M, Pipinis E, et al. 40-Hz auditory steady-state responses and the complex information processing: an exploratory study in healthy young males. PLoS ONE. 2019;14:e0223127.
Cho RY, Konecky RO, Carter CS. Impairments in frontal cortical synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci USA. 2006;103:19878–83.
Abbas AI, Sundiang MJM, Henoch B, Morton MP, Bolkan SS, Park AJ, et al. Somatostatin interneurons facilitate hippocampal-prefrontal synchrony and prefrontal spatial encoding. Neuron. 2018;100:926–939.e3.
Bouvier E, Brouillard F, Molet J, Claverie D, Cabungcal J-H, Cresto N, et al. Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression. Mol Psychiatry. 2017;22:1701–13.
Uhlhaas PJ, Singer W. Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities. Biol Psychiatry. 2015;77:1001–9.
Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R, et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science. 2013;339:1095–9.
Silva SV, Garcia-Souza ÉP, Moura AS, Barja-Fidalgo C. Maternal protein restriction during early lactation induces changes on neutrophil activation and TNF-α production of adult offspring. Inflammation. 2010;33:65–75.
Acknowledgements
We are grateful to Adeline Cottier for technical assistance. Thanks to Prof Umberto Simeoni, Director of the Division of peadiatrics & DOHaD Lab in CHUV. This work was supported by the Swiss-National-Science-Foundation (320030_122419 to PC and KQD), National-Center-of-Competence-in-Research (NCCR)“SYNAPSY-The-Synaptic-Bases-of-Mental-Diseases” (no 51AU40_125759), Damm-Etienne and Alamaya Foundations, as well as by grant from the “Association pour l’information et la recherche sur les maladies rénales génétiques” (AIRG-Switzerland). Special thanks to Jean-Yves Chatton and his team, at the Cellular Imaging Facility (CIF/UNIL). Daniella Dwir is recipient of a grant from the Adrian et Simone Frutiger foundation. All authors of this paper declare no conflict of interest.
Author information
Authors and Affiliations
Contributions
LA wrote the manuscript. LA and JHC performed data acquisition, images quantification, and analyses. CY provided and prepared the animals used. DD, JHC, CY, and KQD conceived the study. DD directly supervised the analyses and contributed to writing the manuscript. All authors reviewed and edited the manuscript.
Corresponding author
Ethics declarations
COMPETING INTERESTS
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Allgäuer, L., Cabungcal, JH., Yzydorczyk, C. et al. Low protein-induced intrauterine growth restriction as a risk factor for schizophrenia phenotype in a rat model: assessing the role of oxidative stress and neuroinflammation interaction. Transl Psychiatry 13, 30 (2023). https://doi.org/10.1038/s41398-023-02322-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-023-02322-8
- Springer Nature Limited